MicroPort CardioFlow Medtech Corp is a medical technology company specializing in cardiovascular devices. It develops, manufactures, and commercializes innovative products for the treatment of structural heart diseases and complex cardiovascular conditions. Key offerings include transcatheter valve systems, such as those for aortic and mitral valve replacements, along with delivery systems and accessories designed to improve patient outcomes in minimally invasive procedures. The company focuses on structural heart interventions, peripheral vascular solutions, and related medtech innovations, serving healthcare providers globally through partnerships and distribution networks. MicroPort CardioFlow Medtech Corp plays a vital role in advancing catheter-based therapies within the medtech sector, addressing unmet needs in cardiology and vascular care.